DEF 14A

Company

Cardiff Oncology, Inc.

Filed

October 16, 2015

Period of Report

December 9, 2015

Accession Number

0001104659-15-071060

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →